Revisión sistemática

Published on 10 de diciembre de 2020 | http://doi.org/10.5867/medwave.2020.11.8080

Remdesivir for the treatment of COVID-19: a living systematic review

Back to article Figure 4.

The relative risk for adverse effects leading to discontinuation for remdesivir versus standard care (prepared by the authors from the study data).